Hinge Health, Inc. <HNGE.N>: Barclays Raises Target Price to $97 From $70
HNGE•Related News

AZZ Inc <AZZ.N>: B. Riley Raises Target Price to $170 From $169
AZZ•

Sana Biotechnology plans IND filing, targets Phase 1/2 start this year for SC451 type 1 diabetes therapy
SANA•

Iqstel forms IQSTEL Operating Holdings to house operating subsidiaries under new structure
IQST•

California Resources Corp <CRC.N>: JP Morgan Cuts Target Price to $77 From $83
CRC•

Keysight Technologies Inc <KEYS.N>: Morgan Stanley Raises Target Price to $400.00 From $350.00
KEYS•